Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.
2.

Associations between HbA1c and continuous glucose monitoring-derived glycaemic variables.

Hirsch IB, Welsh JB, Calhoun P, Puhr S, Walker TC, Price DA.

Diabet Med. 2019 Jul 3. doi: 10.1111/dme.14065. [Epub ahead of print]

PMID:
31267573
3.

Real-World Hypoglycemia Avoidance With a Predictive Low Glucose Alert Does Not Depend on Frequent Screen Views.

Puhr S, Derdzinski M, Parker AS, Welsh JB, Price DA.

J Diabetes Sci Technol. 2019 Apr 3:1932296819840691. doi: 10.1177/1932296819840691. [Epub ahead of print]

PMID:
30943780
4.

Continuous glucose monitoring: an emerging standard of care.

Welsh JB, Thomas R.

Am J Manag Care. 2019 Mar;25(4 Spec No.):SP116-SP119. No abstract available.

5.

Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert.

Puhr S, Derdzinski M, Welsh JB, Parker AS, Walker T, Price DA.

Diabetes Technol Ther. 2019 Apr;21(4):155-158. doi: 10.1089/dia.2018.0359. Epub 2019 Mar 22.

6.

Real-Time Sharing and Following of Continuous Glucose Monitoring Data in Youth.

Welsh JB, Derdzinski M, Parker AS, Puhr S, Jimenez A, Walker T.

Diabetes Ther. 2019 Apr;10(2):751-755. doi: 10.1007/s13300-019-0571-0. Epub 2019 Jan 30.

7.

Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems.

Welsh JB, Gao P, Derdzinski M, Puhr S, Johnson TK, Walker TC, Graham C.

Diabetes Technol Ther. 2019 Mar;21(3):128-132. doi: 10.1089/dia.2018.0374. Epub 2019 Jan 25.

8.

Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes.

Welsh JB, Zhang X, Puhr SA, Johnson TK, Walker TC, Balo AK, Price D.

J Diabetes Sci Technol. 2019 Mar;13(2):254-258. doi: 10.1177/1932296818798816. Epub 2018 Sep 10.

9.

The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.

Puhr S, Calhoun P, Welsh JB, Walker TC.

Diabetes Technol Ther. 2018 Aug;20(8):557-560. doi: 10.1089/dia.2018.0134. Epub 2018 Jul 23.

PMID:
30036082
10.

Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes.

Welsh JB.

Diabetes Technol Ther. 2018 Jun;20(S2):S242-S249. doi: 10.1089/dia.2018.0100. No abstract available.

PMID:
29916736
11.

Manufacturing Process Changes and Reduced Skin Irritations of an Adhesive Patch Used for Continuous Glucose Monitoring Devices.

Gisin V, Chan A, Welsh JB.

J Diabetes Sci Technol. 2018 May;12(3):725-726. doi: 10.1177/1932296817738076. Epub 2017 Oct 27.

12.

Retrospective Analysis of Continuous Glucose Monitoring Data With the Surveillance Error Grid Supports Nonadjunctive Dosing Decisions.

Welsh JB, Walker T, Price D.

J Diabetes Sci Technol. 2017 Sep;11(5):942-946. doi: 10.1177/1932296817694180. Epub 2017 Feb 15.

13.

Stability, Accuracy, and Risk Assessment of a Novel Subcutaneous Glucose Sensor.

Hughes J, Welsh JB, Bhavaraju NC, Vanslyke SJ, Balo AK.

Diabetes Technol Ther. 2017 Jun;19(S3):S21-S24. doi: 10.1089/dia.2017.0072.

14.

Effectiveness of Automated Insulin Management Features of the MiniMed® 640G Sensor-Augmented Insulin Pump.

Zhong A, Choudhary P, McMahon C, Agrawal P, Welsh JB, Cordero TL, Kaufman FR.

Diabetes Technol Ther. 2016 Oct;18(10):657-663. Epub 2016 Sep 27.

15.

Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management.

Choudhary P, Olsen BS, Conget I, Welsh JB, Vorrink L, Shin JJ.

Diabetes Technol Ther. 2016 May;18(5):288-91. doi: 10.1089/dia.2015.0324. Epub 2016 Feb 23.

16.

Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study.

Weiss R, Garg SK, Bode BW, Bailey TS, Ahmann AJ, Schultz KA, Welsh JB, Shin JJ.

Diabetes Technol Ther. 2015 Aug;17(8):542-7. doi: 10.1089/dia.2014.0306. Epub 2015 Jun 2.

17.

Upcoming Devices for Diabetes Management: The Artificial Pancreas as the Hallmark Device.

Lee SW, Welsh JB.

Diabetes Technol Ther. 2015 Aug;17(8):538-41. doi: 10.1089/dia.2014.0303. No abstract available.

PMID:
26237307
18.

Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.

Davis T, Salahi A, Welsh JB, Bailey TS.

Diabetes Obes Metab. 2015 Dec;17(12):1126-32. doi: 10.1111/dom.12542. Epub 2015 Oct 5. Review.

PMID:
26179879
19.

Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.

Weiss R, Garg SK, Bergenstal RM, Klonoff DC, Bode BW, Bailey TS, Thrasher J, Schwartz F, Welsh JB, Kaufman FR; ASPIRE In-Home Study Group.

J Diabetes Sci Technol. 2015 May 18;9(5):1016-20. doi: 10.1177/1932296815586014.

20.

Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps.

Agrawal P, Zhong A, Welsh JB, Shah R, Kaufman FR.

Diabetes Technol Ther. 2015 May;17(5):316-9. doi: 10.1089/dia.2014.0257. Epub 2015 Jan 22.

21.

Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.

Nørgaard K, Shin J, Welsh JB, Gjessing H.

J Diabetes Sci Technol. 2015 Mar;9(2):215-20. doi: 10.1177/1932296814567326. Epub 2015 Jan 14.

22.

Patient behaviors associated with optimum glycemic outcomes with sensor-augmented pump therapy: insights from the STAR 3 study.

Tanenberg RJ, Welsh JB.

Endocr Pract. 2015 Jan;21(1):41-5. doi: 10.4158/EP14187.OR.

PMID:
25100386
23.

Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor.

Bailey TS, Ahmann A, Brazg R, Christiansen M, Garg S, Watkins E, Welsh JB, Lee SW.

Diabetes Technol Ther. 2014 May;16(5):277-83. doi: 10.1089/dia.2013.0222. Epub 2014 Apr 7.

PMID:
24758729
24.

Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study.

Garg SK, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR.

Diabetes Technol Ther. 2014 Mar;16(3):125-30. doi: 10.1089/dia.2013.0219. Epub 2014 Jan 9.

PMID:
24405492
25.

Threshold insulin-pump interruption to reduce hypoglycemia.

Bergenstal RM, Welsh JB, Shin JJ.

N Engl J Med. 2013 Oct 10;369(15):1474. doi: 10.1056/NEJMc1310365. No abstract available.

PMID:
24106952
26.

ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia.

Klonoff DC, Bergenstal RM, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann A, Welsh JB, Lee SW.

J Diabetes Sci Technol. 2013 Jul 1;7(4):1005-10.

27.

Threshold-based insulin-pump interruption for reduction of hypoglycemia.

Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group.

N Engl J Med. 2013 Jul 18;369(3):224-32. doi: 10.1056/NEJMoa1303576. Epub 2013 Jun 22.

28.

Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set.

O'Neal DN, Adhya S, Jenkins A, Ward G, Welsh JB, Voskanyan G.

J Diabetes Sci Technol. 2013 Mar 1;7(2):381-8.

29.

Acceptability and utility of the mySentry remote glucose monitoring system.

Kaiserman K, Buckingham BA, Prakasam G, Gunville F, Slover RH, Wang Y, Nguyen X, Welsh JB.

J Diabetes Sci Technol. 2013 Mar 1;7(2):356-61.

30.

User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for Diabetes.

Welsh JB, Myers SJ, Uhrinak AN, Kaufman FR, Lee SW.

J Diabetes Sci Technol. 2012 Mar 1;6(2):481-2. No abstract available.

31.

Accuracy of the Sof-sensor glucose sensor with the iPro calibration algorithm.

Welsh JB, Kaufman FR, Lee SW.

J Diabetes Sci Technol. 2012 Mar 1;6(2):475-6. No abstract available.

32.

Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.

Buse JB, Kudva YC, Battelino T, Davis SN, Shin J, Welsh JB.

Diabetes Technol Ther. 2012 Jul;14(7):644-7. doi: 10.1089/dia.2011.0294. Epub 2012 Apr 23.

33.

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR.

Diabetes Technol Ther. 2012 Mar;14(3):205-9. doi: 10.1089/dia.2011.0292. Epub 2012 Feb 8.

PMID:
22316089
34.

The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.

Brazg RL, Bailey TS, Garg S, Buckingham BA, Slover RH, Klonoff DC, Nguyen X, Shin J, Welsh JB, Lee SW.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1466-71.

35.

Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.

Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR.

J Diabetes Sci Technol. 2011 Sep 1;5(5):1137-41.

36.

Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group.

Diabetes Care. 2011 Nov;34(11):2403-5. doi: 10.2337/dc11-1248. Epub 2011 Sep 20.

37.

Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study.

Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV.

Pediatr Diabetes. 2012 Feb;13(1):6-11. doi: 10.1111/j.1399-5448.2011.00793.x. Epub 2011 Jul 3.

PMID:
21722284
38.

A report of 7 cases of feline vulval adenocarcinoma.

Welsh JB, Best SJ, Yager JA, Foster RA.

Can Vet J. 2010 Jul;51(7):764-6.

39.

Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database.

Welsh JB, Kannard B, Nogueira K, Kaufman FR, Shah R.

Pediatr Endocrinol Rev. 2010 Aug;7 Suppl 3:413-6.

PMID:
20877255
40.

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group.

N Engl J Med. 2010 Jul 22;363(4):311-20. doi: 10.1056/NEJMoa1002853. Epub 2010 Jun 29. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092.

41.

Designing the modern pump: engineering aspects of continuous subcutaneous insulin infusion software.

Welsh JB, Vargas S, Williams G, Moberg S.

Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S37-42. doi: 10.1089/dia.2009.0188.

PMID:
20515305
42.

Practical considerations in the use of real-time continuous glucose monitoring alerts.

Mastrototaro J, Welsh JB, Lee S.

J Diabetes Sci Technol. 2010 May 1;4(3):733-9. Review.

43.

2HAPI: a microarray data analysis system.

Fink JL, Drewes S, Patel H, Welsh JB, Masys DR, Corbeil J, Gribskov M.

Bioinformatics. 2003 Jul 22;19(11):1443-5.

PMID:
12874061
44.

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.

Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, Sutherland RL, Breit SN, Moskaluk CA, Frierson HF Jr, Hampton GM.

Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3410-5. Epub 2003 Mar 6.

45.

Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.

Frierson HF Jr, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA, Hampton GM.

Am J Pathol. 2002 Oct;161(4):1315-23.

46.

Molecular classification of human carcinomas by use of gene expression signatures.

Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson HF Jr, Hampton GM.

Cancer Res. 2001 Oct 15;61(20):7388-93.

47.

Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF Jr, Hampton GM.

Cancer Res. 2001 Aug 15;61(16):5974-8.

48.

Arrays of arrays for high-throughput gene expression profiling.

Zarrinkar PP, Mainquist JK, Zamora M, Stern D, Welsh JB, Sapinoso LM, Hampton GM, Lockhart DJ.

Genome Res. 2001 Jul;11(7):1256-61.

49.

Temporal gene regulation during HIV-1 infection of human CD4+ T cells.

Corbeil J, Sheeter D, Genini D, Rought S, Leoni L, Du P, Ferguson M, Masys DR, Welsh JB, Fink JL, Sasik R, Huang D, Drenkow J, Richman DD, Gingeras T.

Genome Res. 2001 Jul;11(7):1198-204.

50.

Use of keyword hierarchies to interpret gene expression patterns.

Masys DR, Welsh JB, Lynn Fink J, Gribskov M, Klacansky I, Corbeil J.

Bioinformatics. 2001 Apr;17(4):319-26.

PMID:
11301300

Supplemental Content

Loading ...
Support Center